Does tibolone exacerbate atherosclerosis?

被引：10

作者：

Clarkson, TB ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Comparat Med Clin Res Ctr, Winston Salem, NC 27157 USA

来源：

EUROPEAN HEART JOURNAL | 2006年 / 27卷 / 06期

关键词：

Congenital heart disease; Adult; Adherence to guidelines; Euro Heart Survey;

D O I：

10.1093/eurheartj/ehi724

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：635 / 637

页数：3

共 10 条

[1]

INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J].

ADAMS, MR ;

KAPLAN, JR ;

MANUCK, SB ;

KORITNIK, DR ;

PARKS, JS ;

WOLFE, MS ;

CLARKSON, TB .

ARTERIOSCLEROSIS, 1990, 10 (06) :1051-1057

[2]

The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxy-progesterone acetate on progression of carotid intima-media thickness: the osteoporosis prevention and arterial effects of tiboLone (OPAL) study [J].

Bots, ML ;

Evans, GW ;

Riley, W ;

McBride, KH ;

Paskett, ED ;

Helmond, FA ;

Grobbee, DE .

EUROPEAN HEART JOURNAL, 2006, 27 (06) :746-755

[3]

Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease - HERS B-mode substudy [J].

Byington, RP ;

Furberg, CD ;

Herrington, DM ;

Herd, JA ;

Hunninghake, D ;

Lowery, M ;

Riley, W ;

Craven, T ;

Chaput, L ;

Ireland, CC ;

Applegate, WB .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1692-1697

[4]

CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217

[5]

A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys [J].

Clarkson, TB ;

Anthony, MS ;

Wagner, JD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5396-5404

[6]

ESTROGEN REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES OF POSTMENOPAUSAL WOMEN [J].

ESPELAND, MA ;

APPLEGATE, W ;

FURBERG, CD ;

LEFKOWITZ, D ;

RICE, L ;

HUNNINGHAKE, D .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (10) :1011-1019

[7]

Estrogen in the prevention of atherosclerosis - A randomized, double-blind, placebo-controlled trial [J].

Hodis, HN ;

Mack, WJ ;

Lobo, RA ;

Shoupe, D ;

Sevanian, A ;

Mahrer, PR ;

Selzer, RH ;

Liu, CR ;

Liu, CH ;

Azen, SP .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (11) :939-953

[8]

Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial [J].

Karim, R ;

Mack, WJ ;

Lobo, RA ;

Hwang, J ;

Liu, CR ;

Liu, CH ;

Sevanian, A ;

Hodis, HN .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (04) :366-373

[9]

Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens [J].

Mikkola, TS ;

Anthony, MS ;

Clarkson, TB ;

St Clair, RW .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (04) :523-530

[10]

Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity [J].

von Eckardstein, A ;

Schmiddem, K ;

Hövels, A ;

Gülbahçe, E ;

Schuler-Lüttmann, S ;

Elbers, J ;

Helmond, F ;

Bennink, HJTC ;

Assmann, G .

ATHEROSCLEROSIS, 2001, 159 (02) :433-439

← 1 →